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The epidemiologic transition theory
to describe and explain the spectacular fall in mortality
which has occurred in all currently industrialised countries,
it can also be used to speculate on the likely consequences of
future changes in mortality in countries which are lagging
behind those which have already completed the epidemiolo-
gic transition: will a fall in infectious disease mortality in
currently developing countries lead to a rise in chronic
diseases and accidents?28 In addition, this notion of a more
or less fixed pattern of changes over time in cause specific
mortality may lead us to interpret cross sectional differences
between countries in cause specific mortality as being due to
a different timing of the epidemiologic transition, which in
turn would suggest differences in stage of economic and
social development as likely causes.
In order to live up to these expectations, however, it is
essential to investigate the historical changes in mortality
much more thoroughly than has hitherto been done. Care-
ful reconstruction of national time series of cause specific
mortality are a necessary first step,29 and possibly cause
specific mortality data from the pre-registration era, which
are available for certain subnational populations such as
London8 and Amsterdam,3' would also be useful. System-
atic and comparative descriptive analyses of these time
series may disclose common patterns of change, and
thereby lead to a clearer notion of the transition (or transi-
tions) which have taken place. Finally, we may try to
develop comprehensive hypotheses on the explanation of
the epidemiologic transition(s), perhaps incorporating
recently accumulated evidence on the link between child-
hood deprivation and adult heart disease.3' Clearly, this
enterprise is too exciting to be left to demographers and
geographers.
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AIDS in Spain: lessons learned from a public health disaster
World Health Organisation data currently shows that
Spain has reported the highest figures for AIDS in the
whole European region. At the beginning of the epidemic,
however, the situation was very different, as Spain was one
of the countries with the fewest cases.' The most promi-
nent epidemiological characteristic of HIV infection in
Spain is the great importance of transmission between
intravenous drug users (IVDUs), which accounts for 60%
of all the AIDS cases reported up to 1993. The Spanish
IVDU population could be estimated in 150 000 people; of
these 50% were already infected by HIV.24
This dramatic spread could have several causes, and by
trying to understand these we may be able to avoid
repeating past mistakes we have made as public health
professionals or ordinary citizens. In addition, our experi-
ence in Spain could be of some value to those countries in
which the AIDS problem has not reached this proportion.
A rapid spread of HIV among IVDUs was described in
some western cities at the beginning of the epidemic.5
Spanish data support this pattern of transmission,6 and the
HIV prevalence in IVDUs between 1983 and 1985
increased from 11 to 47%. Recently, the incidence rate in
Spanish IVDUs was accurately measured and was deemed
to be the highest ever reported in western countries - 12
cases per 100 person/years (95%CI 9 6, 14 4) between
1987 and 1992.7 The current high prevalence of the
infection in Spain makes it even more difficult for risk
reduction schemes to succeed. An IVDU who fails to use
clean syringes has a higher risk of HIV infection in
Valencia (prevalence=50%) than in Liverpool (preval-
ence = 3%), to mention one of the European cities with a
good record in risk reduction strategies.38 High prevalence
of HIV infection, however, cannot be considered the only
predictor of a high incidence. In some Italian cities the
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prevalence of infection is similar to that in Spain but
nevertheless the reported incidence rates are lower."'
Why again, is Spain different?
The Spanish response to AIDS in the past 10 years has
been medically oriented and unpragmatic. Since the detec-
tion of the first cases in 1983, expert committees were
created at national and regional levels and later some
health authorities of the autonomous communities and the
national government developed AIDS programmes.
These committees and programmes have focused on case
ascertainment for epidemiological surveillance, produc-
tion of guidelines for health care professionals, and mass
media campaigning. An enormous gap has grown between
these medically and virologically dominated vertical struc-
tures, and the affected or potentially affected people,
which has effectively divorced their needs from the re-
sponse of professionals and the public sector.
As a result of this orientation, AIDS/HIV programmes
have generally been sporadic and there has been no con-
tinuous effort on the ground. There are AIDS policies on
AZT treatment or isolation of patients in almost every
Spanish hospital but no risk reduction schemes or
outreach worker services at the community level. The
clinical management ofHIV related diseases is adequate in
Spain but there is an enormous need for a greater public
health response. An example of the lack of a continuing
commitment to AIDS prevention at the national level is
the fact that while this editorial was being written there
was no one responsible for the national AIDS programme.
The last person in charge was unexpectedly dismissed
from his post, and three months later no new appointment
has been made.
In addition to the lack of continuous risk reduction
oriented community programmes, the existing AIDS pol-
icies in Spain have been severely criticised by the more
conservative groups in the country, especially the Catholic
Church hierarchy. The popularisation of the condom, the
availability of needle exchange schemes, or the widespread
implementation of safer sex programmes among teenagers,
prostitutes, or the gay community have been strongly
opposed in the media, the parliament, and even in the
courts. The public health professionals have been unable,
with a few exceptions, to overcome these barriers and win
the debate on the need for pragmatic public policies.
Jonathan Mann recently pointed out the urgent need to
assess critically the reasons for the failure to apply the
"right things" in the fight against AIDS - a new area of
work which could be called AIDS policy analysis.'2 Spain
is obviously a "good" country in which to apply these
approaches. Meanwhile, some reasons for the weaknesses
of the Spanish AIDS policies can be identified and two
lessons could be learned from this public disaster.
Religious or moral arguments used by conservatives
against public health measures should not be answered in
the ideological arena. Arguments showing the health con-
sequences of the different approaches should be used to
obtain a shift in the public debate towards greater pragma-
tism. The current situation in Spain may be attributed not
only to the active role of the Spanish Catholic Church and
conservatives but to the relative weaknesses of our public
health service compared with the "treatment" side of the
national health service.
Persistence and ground work orientation, with the parti-
cipation of the community, are crucial to public health
responses. The political difficulties of implementing risk
reduction programmes have been perceived by many Spa-
nish public health professionals as an alibi which releases
them responsibility compromising the health of the pub-
lic. Persistence is the only way to create and disseminate
models of good practice, and to have subsequent impact on
policies, because as Nancy Milio said, "projects can
demonstrate, but only policies can perpetuate the effects,
projects can create oases of health, but only policies can
distribute and equalize their benefits"."3
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